Details
Stereochemistry | ABSOLUTE |
Molecular Formula | 2C20H24N2O2.8H2O.AsH3O4 |
Molecular Weight | 934.9004 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 8 / 8 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
C=C[C@@]1([H])CN2CC[C@@]1([H])C[C@@]2([H])[C@@]([H])(c3ccnc4ccc(cc34)OC)O.C=C[C@@]1([H])CN2CC[C@@]1([H])C[C@@]2([H])[C@@]([H])(c3ccnc4ccc(cc34)OC)O.[As](=O)(O)(O)O.O.O.O.O.O.O.O.O
InChI
InChIKey=CDTWVNODIPITIB-QLOUZFAJSA-N
InChI=1S/2C20H24N2O2.AsH3O4.8H2O/c2*1-3-13-12-22-9-7-14(13)10-19(22)20(23)16-6-8-21-18-5-4-15(24-2)11-17(16)18;2-1(3,4)5;;;;;;;;/h2*3-6,8,11,13-14,19-20,23H,1,7,9-10,12H2,2H3;(H3,2,3,4,5);8*1H2/t2*13-,14-,19-,20+;;;;;;;;;/m00........./s1
Molecular Formula | H2O |
Molecular Weight | 18.0153 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Molecular Formula | AsH3O4 |
Molecular Weight | 141.943 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Molecular Formula | C20H24N2O2 |
Molecular Weight | 324.4175 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 4 / 4 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
Pharmacological characterization of multidrug resistant MRP-transfected human tumor cells. | 1994 Nov 15 |
|
Screening for reproductive toxicity in Fundulus heteroclitus by genetic expression profiling. | 1996 |
|
Arsenic-induced neural tube defects in mice: alterations in cell cycle gene expression. | 1996 Nov-Dec |
|
Inorganic and methylated arsenic compounds induce cell death in murine macrophages via different mechanisms. | 1998 Apr |
|
Enhanced transcription factor DNA binding and gene expression induced by arsenite or arsenate in renal slices. | 1999 Jul |
|
Purine nucleoside phosphorylase as a cytosolic arsenate reductase. | 2002 Nov |
|
Genetic variation in genes associated with arsenic metabolism: glutathione S-transferase omega 1-1 and purine nucleoside phosphorylase polymorphisms in European and indigenous Americans. | 2003 Aug |
|
Valproate-induced neural tube defects in folate-binding protein-2 (Folbp2) knockout mice. | 2003 Dec |
|
Arsenite and arsenate activate extracellular signal-regulated kinases 1/2 by an epidermal growth factor receptor-mediated pathway in normal human keratinocytes. | 2003 Dec |
|
Human 3'-phosphoadenosine 5'-phosphosulfate synthetase (isoform 1, brain): kinetic properties of the adenosine triphosphate sulfurylase and adenosine 5'-phosphosulfate kinase domains. | 2004 Apr 13 |
|
Glutathione modulates recombinant rat arsenic (+3 oxidation state) methyltransferase-catalyzed formation of trimethylarsine oxide and trimethylarsine. | 2004 Dec |
|
Arsenic induced inhibition of delta-aminolevulinate dehydratase activity in rat blood and its response to meso 2,3-dimercaptosuccinic acid and monoisoamyl DMSA. | 2004 Mar |
|
Regulation of cytoplasmic stress granules by apoptosis-inducing factor. | 2004 Sep 1 |
|
Developmentally restricted genetic determinants of human arsenic metabolism: association between urinary methylated arsenic and CYT19 polymorphisms in children. | 2005 Jun |
|
Redox regulation of RhoA. | 2006 Dec 5 |
|
Organic anion transporting polypeptide-C mediates arsenic uptake in HEK-293 cells. | 2006 Jul |
|
Glutathione-S-transferase-omega [MMA(V) reductase] knockout mice: enzyme and arsenic species concentrations in tissues after arsenate administration. | 2006 Nov 1 |
|
Glutathione-dependent reduction of arsenate by glycogen phosphorylase a reaction coupled to glycogenolysis. | 2007 Nov |
|
Glutathione-dependent reduction of arsenate by glycogen phosphorylase responsiveness to endogenous and xenobiotic inhibitors. | 2007 Nov |
|
Arsenite-induced cytotoxicity in dorsal root ganglion explants. | 2008 Apr 15 |
|
Effects of inorganic arsenic on the rat and mouse urinary bladder. | 2008 Dec |
|
High dietary fat exacerbates arsenic-induced liver fibrosis in mice. | 2008 Mar |
|
Effects of endogenous hydrogen peroxide and glutathione on the stability of arsenic metabolites in rat bile. | 2008 Oct 1 |
|
Mechanism of thiol-supported arsenate reduction mediated by phosphorolytic-arsenolytic enzymes: II. Enzymatic formation of arsenylated products susceptible for reduction to arsenite by thiols. | 2009 Aug |
|
Effects of different inorganic arsenic species in Cyprinus carpio (Cyprinidae) tissues after short-time exposure: bioaccumulation, biotransformation and biological responses. | 2009 Dec |
|
Fast, quantitative in situ hybridization of rare mRNAs using 14C-standards and phosphorus imaging. | 2009 Dec 15 |
|
Inorganic arsenic modulates the expression of selenoproteins in mouse embryonic stem cell. | 2009 Jun 1 |
|
Disruption of the arsenic (+3 oxidation state) methyltransferase gene in the mouse alters the phenotype for methylation of arsenic and affects distribution and retention of orally administered arsenate. | 2009 Oct |
|
Glutathione-supported arsenate reduction coupled to arsenolysis catalyzed by ornithine carbamoyl transferase. | 2009 Sep 1 |
|
Monomethylarsenic diglutathione transport by the human multidrug resistance protein 1 (MRP1/ABCC1). | 2011 Dec |
|
Role of autophagy in arsenite-induced neurotoxicity: the involvement of α-synuclein. | 2015 Mar 18 |
Patents
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Jun 26 15:08:14 UTC 2021
by
admin
on
Sat Jun 26 15:08:14 UTC 2021
|
Record UNII |
8C15XFK30P
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
CFR |
21 CFR 310.547
Created by
admin on Sat Jun 26 15:08:14 UTC 2021 , Edited by admin on Sat Jun 26 15:08:14 UTC 2021
|
||
|
NCI_THESAURUS |
C271
Created by
admin on Sat Jun 26 15:08:14 UTC 2021 , Edited by admin on Sat Jun 26 15:08:14 UTC 2021
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
208-971-4
Created by
admin on Sat Jun 26 15:08:14 UTC 2021 , Edited by admin on Sat Jun 26 15:08:14 UTC 2021
|
PRIMARY | |||
|
C90738
Created by
admin on Sat Jun 26 15:08:14 UTC 2021 , Edited by admin on Sat Jun 26 15:08:14 UTC 2021
|
PRIMARY | |||
|
73415795
Created by
admin on Sat Jun 26 15:08:14 UTC 2021 , Edited by admin on Sat Jun 26 15:08:14 UTC 2021
|
PRIMARY | |||
|
549-59-7
Created by
admin on Sat Jun 26 15:08:14 UTC 2021 , Edited by admin on Sat Jun 26 15:08:14 UTC 2021
|
PRIMARY | |||
|
8C15XFK30P
Created by
admin on Sat Jun 26 15:08:14 UTC 2021 , Edited by admin on Sat Jun 26 15:08:14 UTC 2021
|
PRIMARY | |||
|
1309255
Created by
admin on Sat Jun 26 15:08:14 UTC 2021 , Edited by admin on Sat Jun 26 15:08:14 UTC 2021
|
PRIMARY | RxNorm |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> SALT/SOLVATE |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |